PRESSURE MOUNTS ON DRUG PRICING: A health-care advocacy group says it will push Maryland lawmakers to address prescription drug prices during the coming legislative session, part of a national response to allegations of price-gouging and the rising cost of the emergency allergy treatment EpiPen, reports Ovetta Wiggins in the Post.
The Maryland Citizens’ Health Initiative announced Thursday they will seek legislation next year that would force drug companies to reveal how they set prices for generic and specialty medications. This year, 10 other states have considered similar legislation. Only Vermont adopted it, Erin Cox of the Sun writes.
Legislation proposed by Maryland Citizens’ Health Initiative would require pharmaceutical companies to provide public notice of price increases and to justify those prices. Additionally, writes Bryan Sears for the Daily Record, the proposal would give the state’s attorney general authorization to go after companies for price gouging. The organization also released a poll it said shows voters are willing to vote for or against legislators based on their votes on this one issue.